113 related articles for article (PubMed ID: 7826846)
1. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis.
Haupt R; Fears TR; Rosso P; Colella R; Loiacono G; de Terlizzi M; Mancini A; Comelli A; Indolfi P; Donfrancesco A
Pediatr Hematol Oncol; 1994; 11(5):499-507. PubMed ID: 7826846
[TBL] [Abstract][Full Text] [Related]
2. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.
Haupt R; Fears TR; Heise A; Gadner H; Loiacono G; De Terlizzi M; Tucker MA
Int J Cancer; 1997 Mar; 71(1):9-13. PubMed ID: 9096658
[TBL] [Abstract][Full Text] [Related]
3. Acute leukemia in association with Langerhans cell histiocytosis.
Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME
Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046
[TBL] [Abstract][Full Text] [Related]
4. High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma.
Sugita K; Furukawa T; Tsuchida M; Okawa Y; Nakazawa S; Akatsuka J; Ohira M; Nishimura K
Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):99-104. PubMed ID: 8447565
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H.X '83 study.
Ceci A; de Terlizzi M; Colella R; Loiacono G; Balducci D; Surico G; Castello M; Testi AM; De Bernardi B; Indolfi P
Med Pediatr Oncol; 1993; 21(4):259-64. PubMed ID: 8469220
[TBL] [Abstract][Full Text] [Related]
6. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
[TBL] [Abstract][Full Text] [Related]
7. Langerhans' cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institution.
Giona F; Caruso R; Testi AM; Moleti ML; Malagnino F; Martelli M; Ruco L; Giannetti GP; Annibali S; Mandelli F
Cancer; 1997 Nov; 80(9):1786-91. PubMed ID: 9351548
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.
Heyn R; Khan F; Ensign LG; Donaldson SS; Ruymann F; Smith MA; Vietti T; Maurer HM
Med Pediatr Oncol; 1994; 23(2):99-106. PubMed ID: 8202048
[TBL] [Abstract][Full Text] [Related]
9. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
10. Langerhans cell histiocytosis and acute leukemia: unusual association in two cases.
Aricò M; Comelli A; Bossi G; Raiteri E; Piombo M; Egeler RM
Med Pediatr Oncol; 1993; 21(4):271-3. PubMed ID: 8469222
[TBL] [Abstract][Full Text] [Related]
11. Re: "Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)" by Viana et al.
Whitlock JA
Med Pediatr Oncol; 1993; 21(5):379. PubMed ID: 8492755
[No Abstract] [Full Text] [Related]
12. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
Valagussa P; Bonadonna G
Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
[No Abstract] [Full Text] [Related]
14. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
Bajorin DF; Motzer RJ; Rodriguez E; Murphy B; Bosl GJ
J Natl Cancer Inst; 1993 Jan; 85(1):60-2. PubMed ID: 7677936
[No Abstract] [Full Text] [Related]
15. Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
Duan MH; Han X; Li J; Zhang W; Zhu TN; Han B; Zhuang JL; Wang SJ; Cao XX; Cai HC; Chen M; Yang C; Zhou DB
Leuk Res; 2016 Mar; 42():43-6. PubMed ID: 26859782
[TBL] [Abstract][Full Text] [Related]
16. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
[TBL] [Abstract][Full Text] [Related]
17. Secondary acute myelogenous leukemia following safe exposure to etoposide.
Stine KC; Saylors RL; Sawyer JR; Becton DL
J Clin Oncol; 1997 Apr; 15(4):1583-6. PubMed ID: 9193356
[TBL] [Abstract][Full Text] [Related]
18. Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis.
Silva ML; Land MG; Maradei S; Otero L; Veith M; Brito G; Klumb C; Fernandez T; Pombo-de-Oliveira MS
Cancer Genet Cytogenet; 2002 May; 135(1):101-2. PubMed ID: 12072208
[TBL] [Abstract][Full Text] [Related]
19. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
[TBL] [Abstract][Full Text] [Related]
20. High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
Kushner BH; Heller G; Cheung NK; Wollner N; Kramer K; Bajorin D; Polyak T; Meyers PA
J Clin Oncol; 1998 Sep; 16(9):3016-20. PubMed ID: 9738570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
